CORBELLI, JODY
CORBELLI, JODY
DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE (attivo dal 28/10/2011 al 31/12/2022)
Phase II study of capecitabine-based concomitant chemoradiation followed by durvalumab as a neoadjuvant strategy in locally advanced rectal cancer: the PANDORA trial
2023 Grassi, E; Zingaretti, C; Petracci, E; Corbelli, J; Papiani, G; Banchelli, I; Valli, I; Frassineti, G L; Passardi, A; Di Bartolomeo, M; Pietrantonio, F; Gelsomino, F; Carandina, I; Banzi, M; Martella, L; Bonetti, A V; Boccaccino, A; Molinari, C; Marisi, G; Ugolini, G; Nanni, O; Tamberi, S
Good performance of platinum-based chemotherapy for high-grade gastroenteropancreatic and unknown primary neuroendocrine neoplasms
2018 Brandi, Giovanni; Paragona, Marco; Campana, Davide; Brighi, Nicole; Bondi, Arrigo; Pantaleo, Maria Abbondanza; Corbelli, Jody; Barbera, Maria Aurelia; Biasco, Guido
Adjuvant Treatment and Follow-up Strategies
2015 Brandi, Giovanni; De Lorenzo, Stefania; Corbelli, Jody
Follow-up del cancro del pancreas esocrino
2015 Agostini Valentina, Barbera Maria Aurelia, Brighi Nicole, Casolino Raffaella, Corbelli Jody, Dall'Olio Filippo Gustavo, De Lorenzo Stefania, De Rosa Francesco, Degli Esposti Claudio, Di Girolamo Stefania, Di Marco Mariacristina, Di Tullio Piergiorgio, Frega Giorgio, Freier Eva, Garajova Ingrid, Gatto Lidia, Grassi Elisa, Katsinas Giovanna, Lolli Cristian, Macchini Marina, Maleddu Alessandra, Mandrioli Anna, Minchillo Santino, Nannini Margherita, Palloni Andrea, Pallotti Maria Caterina, Pantaleo Maria Abbondanza, Paragona Marco, Pini Sara, Saponara Maristella, Vecchiarelli Silvia, Venturi Michela, Verlicchi Lea, Zucchini Giorgia
Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer.
2014 Fornaro L;Cereda S;Aprile G;Di Girolamo S;Santini D;Silvestris N;Lonardi S;Leone F;Milella M;Vivaldi C;Belli C;Bergamo F;Lutrino SE;Filippi R;Russano M;Vaccaro V;Brunetti AE;Rotella V;Falcone A;Barbera MA;Corbelli J;Fasola G;Aglietta M;Zagonel V;Reni M;Vasile E;Brandi G
A multicenter survey on second-line chemotherapy for advanced biliary tract cancer
2013 Vasile E; Cereda S; Lutrino SE; Lonardi S; Leone F; Russano M; Vaccaro V; Del Curatolo S; Corbelli J; Fornaro L; Caponi S; Santini D; Rotella V; Vivaldi C; Di Girolamo S; Filippi R; Cardellino GG; Daniel F; Reni M; Brandi G
Multivariate prognostic factor analysis in patients (pts) with advanced biliary tract cancer (aBTC) treated with second-line chemotherapy (CT)
2013 L. Fornaro; S. Cereda; F. Bergamo; F. Leone; M. Russano; N. Silvestris; J. Corbelli; V. Rotella; C. Vivaldi; G. Brandi
Plasma membrane localization of human equilibrative nucleoside transporter 1 (hENT-1) predicts better outcome of adjuvant gemcitabine in cholangiocarcinoma (CC) patients.
2013 Brandi G; Tavolari S; Vasuri F, Farioli A; Deserti M; Frega G; Corbelli J; Barbera MA; Pantaleo MA; Di Girolamo S; Biasco G.
Prognostic model for patients with advanced biliary tract cancer (ABTC) receiving second-line chemotherapy (CT)
2013 Fornaro L; Cereda S; Bergamo F; Lutrino SE; Leone F; Santini D; Vaccaro V; Silvestris N; Corbelli J; Vasile E; Milella M; Aprile G; Vivaldi C; Barbera A; Filippi R; Caparello C; Mioranza E; Ferrari L; Baldini E; Reni M; Brandi G
Second surgery or chemotherapy for relapse after radical resection of colorectal cancer metastases.
2012 Brandi G;Corbelli J;de Rosa F;Di Girolamo S;Longobardi C;Agostini V;Garajová I;La Rovere S;Ercolani G;Grazi GL;Pinna AD;Biasco G
Asbestos: a putative risk factor for intrahepatic cholangiocarcinoma
2011 Mattioli S; Di Girolamo S; Farioli A; de Rosa F; Curti S; Corbelli J; Longobardi C; Agostini V; Garajovà I; Paragona M; Violante FS; Biasco G; Brandi G
EXPOSURE TO ASBESTOS: A PUTATIVE UNKNOWN RISK FACTOR FOR INTRAHEPATIC CHOLANGIOCARCINOMA
2011 G. Brandi ; S. Di Girolamo ; A. Farioli ; F. de Rosa ; S. Curti ; J. Corbelli ; C. Longobardi ; V. Agostini ; I. Garajovà; M. Paragona ; F. S. Violante ; G. Biasco ; S. Mattioli
Feasibility of triplets (5-FU, oxaliplatin and irinotecan based) in front and subsequent lines of metastatic colorectal cancer patients.
2011 Longobardi C; Brandi G; Bruera G; Corbelli J; de Rosa F; Di Girolamo S; Casolino R; Agostini V; Garajovà I; Biasco G; Ficorella C.
Impact of adjuvant chemotherapy on time to relapse in cholangiocarcinoma.
2011 S. Di Girolamo; E. Nobili; E. Derenzini; F. de Rosa; V. Agostini; G. Ercolani; J. Corbelli; A. Pinna; G. Biasco; G. Brandi
Metronomic capecitabine as second-line treatment after sorafenib for hepatocelllular carcinoma.
2011 de Rosa F; Di Girolamo S; Corbelli J; Longobardi C; Agostini V; Andreone P; Serra C; Piscaglia F; Trevisani F; Golfieri R; Bolondi L; Pinna AD; Biasco G; Brandi G.
Metronomic capecitabine in advanced hepatocellualr cacinoma patients who have failed sorafenib: a phase II study
2011 De Rosa F, Di Girolamo S, Corbelli J, Longobardi C, Agostini V, Andreone P, Serra C, Piscaglia F, Trevisani F, Golfieri R, Bolondi L, Pinna AD, Biasco G, Brandi G
Rapid, marked wash out at contrast-enhanced ultrasound in nodules in cirrhosis should raise the suspicion of cholangiocarcinoma.
2011 Galassi M, Piscaglia F, Lucidi V, Renzulli M, Cescon M, Venerandi L, Corbelli J, Vasuri F, Golfieri R, Bolondi L
Second-line chemotherapy in biliary tract cancer patients.
2011 Corbelli J; Di Girolamo S; de Rosa F; Agostini V; Garajovà I; Longobardi C; Paragona M; Ercolani G; Pinna AD; Biasco G; Brandi G.
Second-line chemotherapy in patients with biliary tract cancer.
2011 G. Brandi; S. Di Girolamo; F. de Rosa; J. Corbelli; V. Agostini; I. Garajova; C. Longobardi; M. Paragona; G. Ercolani; A. D. Pinna; G. Biasco
High prevalence of asbestos exposure in bile duct cancer patients
2010 S. Di Girolamo; F. de Rosa; E. Nobili; V. Agostini; J. Corbelli; G. Biasco; G. Brandi
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Phase II study of capecitabine-based concomitant chemoradiation followed by durvalumab as a neoadjuvant strategy in locally advanced rectal cancer: the PANDORA trial | Grassi, E; Zingaretti, C; Petracci, E; Corbelli, J; Papiani, G; Banchelli, I; Valli, I; Frassinet...i, G L; Passardi, A; Di Bartolomeo, M; Pietrantonio, F; Gelsomino, F; Carandina, I; Banzi, M; Martella, L; Bonetti, A V; Boccaccino, A; Molinari, C; Marisi, G; Ugolini, G; Nanni, O; Tamberi, S | 2023-01-01 | ESMO OPEN | - | 1.01 Articolo in rivista | main.pdf |
| Good performance of platinum-based chemotherapy for high-grade gastroenteropancreatic and unknown primary neuroendocrine neoplasms | Brandi, Giovanni; Paragona, Marco; Campana, Davide; Brighi, Nicole; Bondi, Arrigo; Pantaleo, Mari...a Abbondanza; Corbelli, Jody; Barbera, Maria Aurelia; Biasco, Guido | 2018-01-01 | JOURNAL OF CHEMOTHERAPY | - | 1.01 Articolo in rivista | - |
| Adjuvant Treatment and Follow-up Strategies | Brandi, Giovanni; De Lorenzo, Stefania; Corbelli, Jody | 2015-01-01 | - | Nova Science Publishers, Inc. | 2.01 Capitolo / saggio in libro | - |
| Follow-up del cancro del pancreas esocrino | Agostini Valentina, Barbera Maria Aurelia, Brighi Nicole, Casolino Raffaella, Corbelli Jody, Dall...'Olio Filippo Gustavo, De Lorenzo Stefania, De Rosa Francesco, Degli Esposti Claudio, Di Girolamo Stefania, Di Marco Mariacristina, Di Tullio Piergiorgio, Frega Giorgio, Freier Eva, Garajova Ingrid, Gatto Lidia, Grassi Elisa, Katsinas Giovanna, Lolli Cristian, Macchini Marina, Maleddu Alessandra, Mandrioli Anna, Minchillo Santino, Nannini Margherita, Palloni Andrea, Pallotti Maria Caterina, Pantaleo Maria Abbondanza, Paragona Marco, Pini Sara, Saponara Maristella, Vecchiarelli Silvia, Venturi Michela, Verlicchi Lea, Zucchini Giorgia | 2015-01-01 | - | Bologna University Press | 2.01 Capitolo / saggio in libro | - |
| Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer. | Fornaro L;Cereda S;Aprile G;Di Girolamo S;Santini D;Silvestris N;Lonardi S;Leone F;Milella M;Viva...ldi C;Belli C;Bergamo F;Lutrino SE;Filippi R;Russano M;Vaccaro V;Brunetti AE;Rotella V;Falcone A;Barbera MA;Corbelli J;Fasola G;Aglietta M;Zagonel V;Reni M;Vasile E;Brandi G | 2014-01-01 | BRITISH JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| A multicenter survey on second-line chemotherapy for advanced biliary tract cancer | Vasile E; Cereda S; Lutrino SE; Lonardi S; Leone F; Russano M; Vaccaro V; Del Curatolo S; Corbell...i J; Fornaro L; Caponi S; Santini D; Rotella V; Vivaldi C; Di Girolamo S; Filippi R; Cardellino GG; Daniel F; Reni M; Brandi G | 2013-01-01 | TUMORI | - | 4.03 Poster | - |
| Multivariate prognostic factor analysis in patients (pts) with advanced biliary tract cancer (aBTC) treated with second-line chemotherapy (CT) | L. Fornaro; S. Cereda; F. Bergamo; F. Leone; M. Russano; N. Silvestris; J. Corbelli; V. Rotella; ...C. Vivaldi; G. Brandi | 2013-01-01 | - | - | 4.03 Poster | - |
| Plasma membrane localization of human equilibrative nucleoside transporter 1 (hENT-1) predicts better outcome of adjuvant gemcitabine in cholangiocarcinoma (CC) patients. | Brandi G; Tavolari S; Vasuri F, Farioli A; Deserti M; Frega G; Corbelli J; Barbera MA; Pantaleo M...A; Di Girolamo S; Biasco G. | 2013-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 4.02 Riassunto (Abstract) | - |
| Prognostic model for patients with advanced biliary tract cancer (ABTC) receiving second-line chemotherapy (CT) | Fornaro L; Cereda S; Bergamo F; Lutrino SE; Leone F; Santini D; Vaccaro V; Silvestris N; Corbelli... J; Vasile E; Milella M; Aprile G; Vivaldi C; Barbera A; Filippi R; Caparello C; Mioranza E; Ferrari L; Baldini E; Reni M; Brandi G | 2013-01-01 | TUMORI | - | 4.03 Poster | - |
| Second surgery or chemotherapy for relapse after radical resection of colorectal cancer metastases. | Brandi G;Corbelli J;de Rosa F;Di Girolamo S;Longobardi C;Agostini V;Garajová I;La Rovere S;Ercola...ni G;Grazi GL;Pinna AD;Biasco G | 2012-01-01 | LANGENBECK'S ARCHIVES OF SURGERY | - | 1.01 Articolo in rivista | - |
| Asbestos: a putative risk factor for intrahepatic cholangiocarcinoma | Mattioli S; Di Girolamo S; Farioli A; de Rosa F; Curti S; Corbelli J; Longobardi C; Agostini V; G...arajovà I; Paragona M; Violante FS; Biasco G; Brandi G | 2011-01-01 | I SUPPLEMENTI DI TUMORI | - | 4.03 Poster | - |
| EXPOSURE TO ASBESTOS: A PUTATIVE UNKNOWN RISK FACTOR FOR INTRAHEPATIC CHOLANGIOCARCINOMA |
G. Brandi ; S. Di Girolamo ; A. Farioli ; F. de Rosa ; S. Curti ; J. Corbelli ; C. Longobardi ; V.... Agostini ; I. Garajovà; M. Paragona ; F. S. Violante ; G. Biasco ; S. Mattioli |
2011-01-01 | - | - | 4.03 Poster | - |
| Feasibility of triplets (5-FU, oxaliplatin and irinotecan based) in front and subsequent lines of metastatic colorectal cancer patients. | Longobardi C; Brandi G; Bruera G; Corbelli J; de Rosa F; Di Girolamo S; Casolino R; Agostini V; G...arajovà I; Biasco G; Ficorella C. | 2011-01-01 | I SUPPLEMENTI DI TUMORI | - | 4.03 Poster | - |
| Impact of adjuvant chemotherapy on time to relapse in cholangiocarcinoma. | S. Di Girolamo; E. Nobili; E. Derenzini; F. de Rosa; V. Agostini; G. Ercolani; J. Corbelli; A. Pi...nna; G. Biasco; G. Brandi | 2011-01-01 | - | - | 4.03 Poster | - |
| Metronomic capecitabine as second-line treatment after sorafenib for hepatocelllular carcinoma. | de Rosa F; Di Girolamo S; Corbelli J; Longobardi C; Agostini V; Andreone P; Serra C; Piscaglia F;... Trevisani F; Golfieri R; Bolondi L; Pinna AD; Biasco G; Brandi G. | 2011-01-01 | I SUPPLEMENTI DI TUMORI | - | 4.03 Poster | - |
| Metronomic capecitabine in advanced hepatocellualr cacinoma patients who have failed sorafenib: a phase II study | De Rosa F, Di Girolamo S, Corbelli J, Longobardi C, Agostini V, Andreone P, Serra C, Piscaglia F,... Trevisani F, Golfieri R, Bolondi L, Pinna AD, Biasco G, Brandi G | 2011-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
| Rapid, marked wash out at contrast-enhanced ultrasound in nodules in cirrhosis should raise the suspicion of cholangiocarcinoma. | Galassi M, Piscaglia F, Lucidi V, Renzulli M, Cescon M, Venerandi L, Corbelli J, Vasuri F, Golfie...ri R, Bolondi L | 2011-01-01 | JOURNAL OF HEPATOLOGY | - | 1.06 Abstract in rivista | - |
| Second-line chemotherapy in biliary tract cancer patients. | Corbelli J; Di Girolamo S; de Rosa F; Agostini V; Garajovà I; Longobardi C; Paragona M; Ercolani ...G; Pinna AD; Biasco G; Brandi G. | 2011-01-01 | I SUPPLEMENTI DI TUMORI | - | 4.03 Poster | - |
| Second-line chemotherapy in patients with biliary tract cancer. | G. Brandi; S. Di Girolamo; F. de Rosa; J. Corbelli; V. Agostini; I. Garajova; C. Longobardi; M. P...aragona; G. Ercolani; A. D. Pinna; G. Biasco | 2011-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 4.02 Riassunto (Abstract) | - |
| High prevalence of asbestos exposure in bile duct cancer patients | S. Di Girolamo; F. de Rosa; E. Nobili; V. Agostini; J. Corbelli; G. Biasco; G. Brandi | 2010-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 4.02 Riassunto (Abstract) | - |